Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Med Sci ; 2009 Nov; 63(11) 508-511
Article Dans Anglais | IMSEAR | ID: sea-145463

Résumé

Posterior reversible encephalopathy syndrome is a reversible syndrome characterized by headache, seizures, altered mentation, and loss of vision associated with white matter changes on imaging. We report here a 27 year-old lady three weeks postpartum, presenting with posterior reversible encephalopathy syndrome. She was treated successfully with antihypertensives and showed dramatic improvement. This condition is important to recognize and needs to be treated promptly to prevent morbidity and mortality in pregnancy and postpartum.


Sujets)
Antagonistes alpha-adrénergiques/usage thérapeutique , Antagonistes bêta-adrénergiques/usage thérapeutique , Adulte , Amlodipine/usage thérapeutique , Antihypertenseurs/usage thérapeutique , Cécité corticale/étiologie , Éclampsie/traitement médicamenteux , Femelle , Humains , Labétalol/usage thérapeutique , Leucoencéphalopathie postérieure/traitement médicamenteux , Leucoencéphalopathie postérieure/étiologie , Période du postpartum , Grossesse , Facteurs temps
2.
Article Dans Anglais | IMSEAR | ID: sea-46455

Résumé

Drug interactions (DIs) represent an important and widely under recognized source of medication errors. An interaction is said to occur when the effects of one drug are changed by the presence of another drug(s), food, drink or an environmental chemical. When a therapeutic combination could lead to an unexpected change in the condition of the patient, this would be described as an interaction of potential clinical significance. DIs can arise in numerous ways; such as pharmacodynamic interaction, in which receptor effects of different agents interacts to produce synergy or antagonism of drug effects. In pharmacokinetic interaction, the blood levels of given agents may be raised or lowered based on the type of interaction. Special attention and thorough monitoring is needed for the patients who are predisposed to develop DIs and those on drugs with narrow therapeutic index. DIs can be a very important contributory factor for the occurrence of adverse drug reactions and adverse drug events. DIs monitoring programs should be initiated and strengthened in order to minimize their occurrence. Herbal drug interactions and DIs comprising over the counter medicines should also be considered seriously.


Sujets)
Interactions médicamenteuses , Humains , Erreurs de médication/prévention et contrôle , Facteurs de risque
SÉLECTION CITATIONS
Détails de la recherche